CLIMB BIO INC

CLYMNASDAQ

🏆 #2219 by market capEarnings Nov 5US Equity

$395.09▲ $7.98 (+2.02%)

Simulated price

1h—

24h▲ 2.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$778M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

57

Weak

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.18

Expected

-0.21

beat

+14.00%

YoY −38.50%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.18

beat

Q2 2026

-0.20

beat

Q1 2026

-0.26

miss

Q4 2025

-0.19

miss